Brello Health Pricing: Prepaid 3-Month Costs vs PlexusDx Ongoing Rates

Last reviewed: September 15, 2026 Last updated: September 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Brello Health does not offer separate first-month and refill pricing. Instead, it charges a consistent prepaid rate: $399 every three months for compounded semaglutide injection and $499 every eleven weeks for compounded tirzepatide injection. Those figures translate to a per-month equivalent of $133 for semaglutide (our calculation from the $399 ÷ 3 prepaid structure) and a true twelve-month average of $196.58 per month for tirzepatide (our calculation accounting for the eleven-week rebill cadence). Brello's semaglutide is $432 less expensive over twelve months than PlexusDx's three-month commitment rate ($1,596 versus $2,028), and its tirzepatide is $869 less ($2,359 versus $3,228). The prepaid model requires $399 or $499 upfront and a three-month minimum commitment; PlexusDx offers month-to-month flexibility at higher per-month rates and discounted commitment plans that bill monthly rather than in lump sums. No membership fees apply at either provider, and both use compounded medications prepared by licensed pharmacies.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

At-a-glance comparison

Brello Health pricing captured September 4, 2026, from brellohealth.com and tirzepatidewoo.brellohealth.com. PlexusDx pricing current as of September 15, 2026. Monthly equivalents and twelve-month totals are our calculations.

Understanding Brello's prepaid structure

Brello Health operates on a three-month minimum commitment model. You pay $399 upfront for three months of compounded semaglutide injection, delivered in a single shipment. The program then renews at the same $399 rate every three months (renewal timing for semaglutide should be confirmed at checkout). For compounded tirzepatide injection, you pay $499 upfront for eleven weeks of medication, and the charge rebills every eleven weeks at the same $499 rate; Brello's checkout page states "cancel anytime" for tirzepatide, but semaglutide cancellation terms were not fully documented in our verification and should be confirmed before purchase.

Brello advertises a "$133 per month" rate for semaglutide and "$166.33 per month" for tirzepatide. Both figures are per-month equivalents of the prepaid blocks—$399 divided by three equals $133, and $499 divided by three equals $166.33. The $166.33 tirzepatide figure assumes exactly three months per charge, but because Brello rebills every eleven weeks (not twelve), the true twelve-month average is slightly higher. Fifty-two weeks divided by eleven weeks equals 4.727 billing cycles per year, so the annual cost is $499 × 4.727 = $2,359, or $196.58 per month (our calculation). The difference between the advertised $166.33 and the true $196.58 stems from the eleven-week cadence compressing slightly more billing events into a calendar year.

No membership fees, consultation fees, or shipping fees apply. Medication, provider visit, prescription, and shipping are included in the prepaid charge. The same flat rate applies at every dose; Brello does not publish tiered pricing based on dose strength.

Normalized twelve-month cost calculations

Brello Health semaglutide

• Structure: $399 every three months
• Cycles per year: 4
• Twelve-month total: $399 × 4 = $1,596
• Effective monthly rate: $1,596 ÷ 12 = $133 per month (our calculation)

Brello Health tirzepatide

• Structure: $499 every eleven weeks
• Cycles per year: 52 weeks ÷ 11 weeks = 4.727
• Twelve-month total: $499 × 4.727 = $2,359 (our calculation)
• Effective monthly rate: $2,359 ÷ 12 = $196.58 per month (our calculation)

PlexusDx semaglutide

• Month-to-month: $189 × 12 = $2,268 annual total
• Three-month commitment: $169 × 12 = $2,028 annual total (billed monthly at $169)
• Six-month commitment: $149 × 12 = $1,788 annual total (billed monthly at $149)

PlexusDx tirzepatide

• Month-to-month: $289 × 12 = $3,468 annual total
• Three-month commitment: $269 × 12 = $3,228 annual total (billed monthly at $269)
• Six-month commitment: $249 × 12 = $2,988 annual total (billed monthly at $249)

Brello's semaglutide saves $432 over twelve months compared to PlexusDx's three-month commitment rate, and $672 compared to the month-to-month rate. Brello's tirzepatide saves $869 compared to PlexusDx's three-month commitment and $1,109 compared to month-to-month. PlexusDx's six-month semaglutide commitment ($1,788 annually) comes within $192 of Brello's prepaid semaglutide, and its six-month tirzepatide commitment ($2,988) is $629 more than Brello's tirzepatide over twelve months.

Like-for-like three-month comparison

Brello's three-month prepaid block is directly comparable to PlexusDx's three-month commitment plan. Both require a three-month minimum; the difference lies in billing structure and upfront cash requirement.

Brello's semaglutide requires $399 upfront versus PlexusDx's $507 total outlay over the first three months, and saves $432 annually. Brello's tirzepatide requires $499 upfront versus PlexusDx's $807 over the first three months, and saves $869 annually. The tradeoff is cash-flow flexibility: Brello collects the full quarter in advance, while PlexusDx spreads the same commitment period across three monthly charges.

Decision factors

Upfront cash requirement

Brello asks for $399 or $499 at checkout before your first shipment. If that upfront sum fits your budget and you are confident in a three-month (or eleven-week) commitment, the prepaid model delivers a lower annual cost. PlexusDx's three-month commitment bills monthly, so your first charge is $169 or $269, with two more identical charges over the next sixty days. The total outlay over three months is higher at PlexusDx, but the monthly cadence may be easier to manage.

Billing predictability and eleven-week cadence

Brello's semaglutide rebills every three months on a predictable calendar. Its tirzepatide rebills every eleven weeks, which means your billing date shifts forward by about one week each cycle. Over twelve months you will see 4.727 tirzepatide charges instead of exactly four, pushing the true monthly average to $196.58 rather than the advertised $166.33. PlexusDx bills on the same day every month regardless of medication, which simplifies budgeting and aligns with other monthly expenses.

Cancellation and renewal terms

Brello states "cancel anytime" for tirzepatide on its checkout page (captured September 4, 2026). Semaglutide is described as a "three-month minimum commitment," but specific cancellation and renewal timing were not documented in our verification. We recommend confirming whether you may cancel after the first three-month block or whether the program auto-renews for additional quarters, and what notice period applies. PlexusDx's month-to-month plan has no minimum commitment; three-month and six-month commitments require that you stay for the committed period, after which you may switch to month-to-month or cancel without penalty.

Route and formulation

Both providers offer compounded semaglutide and tirzepatide injections prepared by licensed compounding pharmacies. Neither offers branded Wegovy, Ozempic, Mounjaro, or Zepbound. Brello does not list oral or sublingual formulations in the verified evidence. PlexusDx also offers compounded semaglutide and tirzepatide in oral capsule form at different price points, which may be relevant if you prefer to avoid injections.

Same-price-at-every-dose policy

Both Brello and PlexusDx charge the same flat rate regardless of dose strength. You pay $399 per quarter at Brello whether you are on the starting dose or a higher maintenance dose of semaglutide, and $189 per month at PlexusDx month-to-month for any semaglutide dose. This structure eliminates dose-escalation surprises and simplifies long-term budgeting.

Choose Brello Health if…

• You can comfortably pay $399 (semaglutide) or $499 (tirzepatide) upfront and prefer the lowest possible annual cost.
• You are confident in a three-month minimum commitment and do not need month-to-month flexibility in the early phase of treatment.
• You are comfortable with an eleven-week billing cycle for tirzepatide and have verified current cancellation terms at checkout.
• You want an all-inclusive prepaid block with no separate membership or consultation fees.

Choose PlexusDx if…

• You prefer month-to-month flexibility with no upfront lump sum and the freedom to cancel anytime (month-to-month plan).
• You want predictable monthly billing on the same calendar day every month, regardless of medication.
• You are considering oral capsules in addition to or instead of injections.
• You value a documented review record; PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026).
• You want a six-month commitment option that brings the per-month cost closer to Brello's prepaid rate while preserving monthly billing ($149/month semaglutide, $249/month tirzepatide).

Where PlexusDx fits in your decision

PlexusDx offers three commitment tiers for both compounded semaglutide and tirzepatide injections. The month-to-month plan ($189 semaglutide, $289 tirzepatide) carries no minimum commitment and bills on the same day every month. The three-month commitment ($169 semaglutide, $269 tirzepatide) reduces the per-month rate by $20 and still bills monthly rather than in a lump sum. The six-month commitment ($149 semaglutide, $249 tirzepatide) brings the annual cost to $1,788 for semaglutide and $2,988 for tirzepatide—$192 and $629 more than Brello's respective prepaid totals, but with monthly billing and no quarterly upfront charges.

All PlexusDx plans include the provider visit, prescription, medication, and shipping at the published price. There are no membership fees, no consultation fees, and no separate charges for dose adjustments. The same price applies at every dose, and you may add optional support services (such as health coaching) separately if desired. If you start on a commitment plan and wish to cancel before the term ends, you may do so by paying the difference between the commitment rate and the month-to-month rate for the months you used; after the commitment period you may switch to month-to-month or renew another commitment term.

PlexusDx also offers compounded semaglutide and tirzepatide in oral capsule form, which may be preferable if you want to avoid injections. Oral semaglutide is $289 per month month-to-month, $269 per month on a three-month commitment, and $249 per month on a six-month commitment. Oral tirzepatide is $349 per month month-to-month, $299 per month on a three-month commitment, and $279 per month on a six-month commitment. A microdose GLP-1 injection option is available at $129 per month month-to-month for maintenance or slow titration.

Methodology and freshness

We captured Brello Health's pricing from its public checkout pages on September 4, 2026 (brellohealth.com and tirzepatidewoo.brellohealth.com). Semaglutide is listed at $399 for three months; tirzepatide is listed at $499 for eleven weeks. PlexusDx pricing is current as of September 15, 2026, and is published on product pages at plexusdx.com. All per-month equivalents, three-month upfront totals, and twelve-month cost projections are our calculations, derived by multiplying the verified per-period charge by the appropriate number of billing cycles and dividing by twelve where indicated. We verified Brello's Trustpilot profile existence on September 4, 2026, but no rating, volume, or negative-theme data was available in that verification pass; readers should check current reviews directly. Semaglutide renewal timing and cancellation terms for Brello were flagged for confirmation at checkout. Tirzepatide cancellation is documented as "cancel anytime" on Brello's tirzepatide checkout page. No promotional codes or discount arithmetic were used; all figures reflect standard published or checkout-displayed rates. We encourage readers to confirm all terms, billing cadence, cancellation policies, and current pricing at each provider's checkout before committing.

Frequently Asked Questions

Does Brello Health charge more after the first three months?

No. Brello charges the same prepaid rate every cycle: $399 every three months for semaglutide and $499 every eleven weeks for tirzepatide. There is no separate introductory or first-month discount followed by a higher refill price. The rate remains constant as long as you continue treatment.

Why is Brello's advertised tirzepatide rate different from the true twelve-month average?

Brello advertises $166.33 per month for tirzepatide by dividing $499 by three. However, because the medication rebills every eleven weeks rather than every twelve, you will be charged 4.727 times per year instead of exactly four times. That works out to $2,359 annually, or $196.58 per month. The eleven-week cadence compresses slightly more billing events into a calendar year.

Can I cancel Brello after the first prepaid block?

Brello's tirzepatide page states "cancel anytime." Semaglutide is described as a three-month minimum commitment, but specific renewal and cancellation terms were not documented in our verification. Confirm at checkout whether the program auto-renews, what notice period applies, and whether you may cancel after the initial three-month block without additional charges.

How does PlexusDx's three-month commitment compare to Brello's three-month prepaid?

Both require a three-month minimum. Brello charges $399 upfront for semaglutide ($1,596 annually) and bills the full quarter in advance. PlexusDx's three-month commitment is $169 per month billed monthly ($2,028 annually), so your first charge is $169 rather than $399. Over twelve months Brello's semaglutide costs $432 less, but PlexusDx spreads the commitment across three monthly payments instead of one lump sum.

Do either provider's prices increase when my dose goes up?

No. Both Brello and PlexusDx use a same-price-at-every-dose model. You pay the same flat rate whether you are on the starting dose or a higher maintenance dose, which eliminates dose-escalation cost surprises and simplifies long-term budgeting.

Sources

• Brello Health semaglutide pricing and program structure, https://www.brellohealth.com/home1, accessed September 4, 2026
• Brello Health tirzepatide pricing and billing cadence, https://tirzepatidewoo.brellohealth.com/, accessed September 4, 2026
• Brello Health Trustpilot profile, https://www.trustpilot.com/review/brellohealth.com, accessed September 4, 2026
• PlexusDx pricing and commitment terms, https://plexusdx.com/products/semaglutide-injection and https://plexusdx.com/products/tirzepatide-injection, accessed September 15, 2026
• PlexusDx Trustpilot rating, https://www.trustpilot.com/review/plexusdx.com, accessed September 9, 2026

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.